InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ALUMIS INC.

ALMS Clue Score37
United States Fiscal year ends December CIK 0001847367 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

75
Insider
Date
Role
Action
Shares
Price
Amount
Mark Christopher Bradley
2 Nov 2026
Chief Development Officer
Sell
623
$6.52
$4.06K
Jorn Drappa
2 Nov 2026
Chief Medical Officer
Sell
593
$6.52
$3.87K
David M Goldstein
2 Nov 2026
Chief Scientific Officer
Sell
629
$6.52
$4.10K
Roy C. Hardiman
2 Nov 2026
Chief Business & Strategy Ofcr
Sell
652
$6.52
$4.25K
Sanam Pangali
2 Nov 2026
Chief Legal Officer
Sell
332
$6.52
$2.16K
John R. Schroer
2 Nov 2026
Chief Financial Officer
Sell
794
$6.52
$5.18K
Srinivas Akkaraju
8 Sep 2026
Director
Buy indirect
273,290
$10.63
$2.90M
Srinivas Akkaraju
8 Sep 2026
Director
Buy indirect
273,291
$10.63
$2.90M
Srinivas Akkaraju
8 Sep 2026
Director
Sell indirect
48,065
$10.55
$507.01K
Srinivas Akkaraju
8 Sep 2026
Director
Sell indirect
48,066
$10.55
$507.02K
Srinivas Akkaraju
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
Srinivas Akkaraju
4 Sep 2026
Director
Buy indirect
220,070
$11.17
$2.46M
Mark Christopher Bradley
3 Aug 2026
Chief Development Officer
Sell
2,572
$26.37
$67.82K
Jorn Drappa
3 Aug 2026
Chief Medical Officer
Sell
2,447
$26.37
$64.53K
David M Goldstein
3 Aug 2026
Chief Scientific Officer
Sell
2,596
$26.37
$68.46K
Roy C. Hardiman
3 Aug 2026
Chief Business & Strategy Ofcr
Sell
2,692
$26.37
$70.99K
Sanam Pangali
3 Aug 2026
Chief Legal Officer
Sell
1,364
$26.37
$35.97K
John R. Schroer
3 Aug 2026
Chief Financial Officer
Sell
3,282
$26.37
$86.55K
Sanam Pangali
6 Jul 2026
Chief Legal Officer
Sold after exercise
5,000
$28.00
$140.00K
Jorn Drappa
22 May 2026
Chief Medical Officer
Exercised, kept
15,535
$5.06
$78.61K
Jorn Drappa
22 May 2026
Chief Medical Officer
Exercised, kept
11,317
$8.84
$100.04K
Srinivas Akkaraju
9 Jan 2026
Director
Buy indirect
588,235
$17.00
$10.00M
James B. Tananbaum
8 Jan 2026
Director
Buy indirect
294,117
$17.00
$5.00M
James B. Tananbaum
8 Jan 2026
Director
Buy indirect
117,647
$17.00
$2.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Capital Management VI LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
294,117
$17.00
$5.00M
Foresite Labs, LLC
8 Jan 2026
10% owner
Buy indirect
117,647
$17.00
$2.00M
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
51,380
$10.73
$551.31K
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
70,028
$10.01
$700.98K
Srinivas Akkaraju
5 Dec 2025
Director
Buy indirect
64,969
$8.95
$581.47K
Srinivas Akkaraju
4 Dec 2025
Director
Buy indirect
66,027
$8.18
$540.10K
Srinivas Akkaraju
3 Dec 2025
Director
Buy indirect
100,000
$7.75
$775.00K
Srinivas Akkaraju
2 Dec 2025
Director
Buy indirect
96,000
$7.55
$724.80K
Srinivas Akkaraju
1 Dec 2025
Director
Buy indirect
86,350
$7.46
$644.17K
Srinivas Akkaraju
28 Nov 2025
Director
Buy indirect
38,702
$7.64
$295.68K
Srinivas Akkaraju
26 Nov 2025
Director
Buy indirect
48,537
$7.64
$370.82K
Foresite Labs, LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
James B. Tananbaum
21 Nov 2025
Director
Buy indirect
72,212
$7.38
$532.92K
Foresite Capital Management VI LLC
21 Nov 2025
10% owner
Buy indirect
72,212
$7.38
$532.92K
Srinivas Akkaraju
20 Nov 2025
Director
Buy indirect
125,743
$7.20
$905.35K
Srinivas Akkaraju
19 Nov 2025
Director
Buy indirect
137,772
$6.56
$903.78K
James B. Tananbaum
19 Nov 2025
Director
Buy indirect
190,500
$6.56
$1.25M
Foresite Capital Management VI LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
Foresite Labs, LLC
19 Nov 2025
10% owner
Buy indirect
190,500
$6.56
$1.25M
Srinivas Akkaraju
18 Nov 2025
Director
Buy indirect
102,652
$6.05
$621.04K
James B. Tananbaum
18 Nov 2025
Director
Buy indirect
117,374
$6.19
$726.55K
Foresite Capital Management VI LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
Foresite Labs, LLC
18 Nov 2025
10% owner
Buy indirect
117,374
$6.19
$726.55K
Srinivas Akkaraju
17 Nov 2025
Director
Buy indirect
914
$5.51
$5.04K
James B. Tananbaum
17 Nov 2025
Director
Buy indirect
150,000
$5.59
$838.50K
James B. Tananbaum
17 Nov 2025
Director
Buy indirect
50,000
$5.60
$280.00K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Capital Management VI LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
150,000
$5.59
$838.50K
Foresite Labs, LLC
17 Nov 2025
10% owner
Buy indirect
50,000
$5.60
$280.00K
Srinivas Akkaraju
13 Nov 2025
Director
Buy indirect
276,179
$5.25
$1.45M
Foresite Capital Management VI LLC
6 May 2025
10% owner
Buy indirect
20,000
$4.34
$86.80K
Foresite Labs, LLC
6 May 2025
10% owner
Buy indirect
20,000
$4.34
$86.80K
James B. Tananbaum
6 May 2025
Director
Buy indirect
20,000
$4.34
$86.80K
Srinivas Akkaraju
5 May 2025
Director
Buy indirect
22,002
$5.27
$115.95K
Srinivas Akkaraju
5 May 2025
Director
Buy indirect
138,368
$4.58
$633.73K
Srinivas Akkaraju
2 May 2025
Director
Buy indirect
159,920
$4.55
$727.64K
Foresite Capital Management VI LLC
2 May 2025
10% owner
Buy indirect
25,000
$4.62
$115.50K
Foresite Labs, LLC
2 May 2025
10% owner
Buy indirect
25,000
$4.62
$115.50K
James B. Tananbaum
2 May 2025
Director
Buy indirect
25,000
$4.62
$115.50K
Alan Colowick
2 Apr 2025
Director
Buy indirect
2,300
$7.49
$17.24K
Martin Babler
1 Apr 2025
President, CEO and Chairman
Buy indirect
15,650
$6.44
$100.73K
Alan Colowick
1 Apr 2025
Director
Buy indirect
16,104
$6.97
$112.31K
James B. Tananbaum
1 Jul 2024
Director
Buy indirect
2,187,500
$16.00
$35.00M
James B. Tananbaum
1 Jul 2024
Director
Buy indirect
312,500
$16.00
$5.00M
Foresite Capital Management V, LLC
1 Jul 2024
10% owner
Buy indirect
2,187,500
$16.00
$35.00M
Foresite Capital Management V, LLC
1 Jul 2024
10% owner
Buy indirect
312,500
$16.00
$5.00M
Foresite Labs, LLC
1 Jul 2024
10% owner
Buy indirect
2,187,500
$16.00
$35.00M
Foresite Labs, LLC
1 Jul 2024
10% owner
Buy indirect
312,500
$16.00
$5.00M

What was left out

Form 4 filings counted 93
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 69,669,054
History held since 1 Jul 2024